Applications focused on ICP/MS | LabRulez ICPMS

Validating performance of an Agilent ICP‑MS for USP <232>/<233> & ICH Q3D(R2)/Q2(R1)

Applications

| 2022 | Agilent Technologies

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Analysis of Artificial Tear Eye Drops For Elemental Impurities

Applications

| 2022 | Agilent Technologies

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Analysis of Elemental Impurities in Synthetic Oligonucleotides by ICP-MS

Applications

| 2023 | Agilent Technologies

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Analysis of Elemental Impurities in Oral Drug Products Using ICPMS-2040/2050 ―ICH Q3D

Applications

| 2023 | Shimadzu

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

Determination of Extractable and Leachable Elements Using ICP-MS

Applications

| 2022 | Agilent Technologies

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Validation of quantitative method for determination of elemental impurities in pharmaceutical products following USP 232/233 on ICPMS-2030

Applications

| 2019 | Shimadzu

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

Analysis of ICH Q3D Guideline for Elemental Impurities in Drug Products Using ICPMS-2030

Applications

| 2016 | Shimadzu

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

Analysis of elemental impurities in pharmaceutical products in accordance with USP General Chapters <232> and <233>

Applications

| 2022 | Thermo Fisher Scientific

ICP/MS, ICP/OES

Instrumentation

ICP/MS, ICP/OES

Manufacturer

Thermo Fisher Scientific

Industries

Pharma & Biopharma

Validation of Analysis Method Using ICPMS-2030 Based on USP <233> ELEMENTAL IMPURITIES - PROCEDURES

Applications

| 2020 | Shimadzu

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

MULTIMODAL IMAGING OF PHOTOSENSITIZERS IN 3D TUMOR CELL MODELS

Applications

| 2018 | Shimadzu

ICP/MS, Laser ablation

Instrumentation

ICP/MS, Laser ablation

Manufacturer

Shimadzu, Tekmar Teledyne

Industries

Clinical Research

Applications focused on ICP/MS | LabRulez ICPMS

Validating performance of an Agilent ICP‑MS for USP <232>/<233> & ICH Q3D(R2)/Q2(R1)

Analysis of Artificial Tear Eye Drops For Elemental Impurities

Analysis of Elemental Impurities in Synthetic Oligonucleotides by ICP-MS

Analysis of Elemental Impurities in Oral Drug Products Using ICPMS-2040/2050 ―ICH Q3D

Determination of Extractable and Leachable Elements Using ICP-MS

Validation of quantitative method for determination of elemental impurities in pharmaceutical products following USP 232/233 on ICPMS-2030

Analysis of ICH Q3D Guideline for Elemental Impurities in Drug Products Using ICPMS-2030

Analysis of elemental impurities in pharmaceutical products in accordance with USP General Chapters <232> and <233>

Validation of Analysis Method Using ICPMS-2030 Based on USP <233> ELEMENTAL IMPURITIES - PROCEDURES

MULTIMODAL IMAGING OF PHOTOSENSITIZERS IN 3D TUMOR CELL MODELS

Related content

Material genetics will be pursued by the AMULET project, which succeeded in the Excellent Research Call

We are trying to succeed with the spin-off company Galochrom

V4+ Conference on Environment and Health in Central Europe